Evidence map›Paper›PMID 35912374›Full record

ReviewEnvironment systems & decisions2023

(Re)Conceptualizing decision-making tools in a risk governance framework for emerging technologies-the case of nanomaterials.

Martin Mullins, Martin Himly, Isabel Rodríguez Llopis, Irini Furxhi, Sabine Hofer, Norbert Hofstätter, Peter Wick, Daina Romeo, Dana Küehnel, Kirsi Siivola and 8 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Environment systems & decisions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Martin MullinsTransgero Limited, Cullinagh, Newcastle West, Co., Limerick, Ireland.
Martin HimlyDepartment of Biosciences, Paris Lodron University of Salzburg (PLUS), 5020 Salzburg, Austria.ORCID 0000-0001-5416-085X
Isabel Rodríguez LlopisGAIKER Technology Centre, Basque Research and Technology Alliance, (BRTA) ES, Gipuzkoa, Spain.
Irini FurxhiTransgero Limited, Cullinagh, Newcastle West, Co., Limerick, Ireland.
Sabine HoferDepartment of Biosciences, Paris Lodron University of Salzburg (PLUS), 5020 Salzburg, Austria.ORCID 0000-0003-4986-3539
Norbert HofstätterDepartment of Biosciences, Paris Lodron University of Salzburg (PLUS), 5020 Salzburg, Austria.ORCID 0000-0003-0207-0654
Peter WickParticles-Biology Interactions Laboratory, Empa, Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
Daina RomeoParticles-Biology Interactions Laboratory, Empa, Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
Dana KüehnelDepartment Bioanalytical Ecotoxicology (BIOTOX), Helmholtz Centre for Environmental Research - UFZ, Permoserstraße 15, 04318 Leipzig, Germany.
Kirsi SiivolaFinnish Institute of Occupational Health, Työterveyslaitos, Box 40, 00032 Helsinki, Finland.ORCID 0000-0001-8161-3308
Julia CatalánFinnish Institute of Occupational Health, Työterveyslaitos, Box 40, 00032 Helsinki, Finland.ORCID 0000-0003-2936-242X
Kerstin Hund-RinkeFraunhofer Institute for Molecular Biology and Applied Ecology IME, Auf dem Aberg 1, 57392 Schmallenberg, Germany.
Ioannis XiarchosResearch Lab of Advanced Composite, Nanomaterials, and Nanotechnology (R-NanoLab), School of Chemical Engineering, National Technical University of Athens, 9 Heroon Polytechniou str, 15780 Zographos, Athens Greece.
Shona LinehanManagement, Cairnes School of Business and Economics, National University of Ireland Galway, Galway, Ireland.
Daan SchuurbiersDe Proeffabriek Josef Israelslaan 63, NL-6813 JB Arnhem, The Netherlands.
Amaia García BilbaoGAIKER Technology Centre, Basque Research and Technology Alliance, (BRTA) ES, Gipuzkoa, Spain.
Leire BarruetabeñaGAIKER Technology Centre, Basque Research and Technology Alliance, (BRTA) ES, Gipuzkoa, Spain.
Damjana DrobneDepartment Biology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utility of decision-making tools for the risk governance of nanotechnology is at the core of this paper. Those working in nanotechnology risk management have been prolific in creating such tools, many derived from European FP7 and H2020-funded projects. What is less clear is how such tools might assist the overarching ambition of creating a fair system of risk governance. In this paper, we reflect upon the role that tools might and should play in any system of risk governance. With many tools designed for the risk governance of this emerging technology falling into disuse, this paper provides an overview of extant tools and addresses their potential shortcomings. We also posit the need for a data readiness tool. With the EUs NMP13 family of research consortia about to report to the Commission on ways forward in terms of risk governance of this domain, this is a timely intervention on an important element of any risk governance system.

Indexed as

Data qualityDecision-making toolsNanotechnologyRisk assessmentRisk governanceRisk management

Identifiers

PMID35912374
PMCPMC9309004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.